# OnCo record nct04557449 (trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/trials/nct04557449/>
  a schema:MedicalTrial ;
  onco:kind "trial" ;
  schema:identifier "nct04557449", "NCT04557449" ;
  schema:name "Study to Test the Safety and Tolerability of PF-07220060 in Participants With Advance Solid Tumors"@en ;
  schema:description "A phase 2 trial of Atirmociclib, Letrozole, Fulvestrant in prostate cancer, run by Pfizer, active and no longer recruiting."@en ;
  schema:url <https://onco.cc/trials/nct04557449/> ;
  schema:dateModified "2026-09-16"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/study/NCT04557449> ;
  onco:status "active" ;
  onco:tag "ctgov-ingest" ;
  onco:phase "2" ;
  schema:startDate "2020-09-23" ;
  onco:cancers <https://onco.cc/cancers/prostate/> ;
  onco:technologies <https://onco.cc/technologies/cdk46-inhibitor/> ;
  onco:drugs <https://onco.cc/drugs/atirmociclib/>, <https://onco.cc/drugs/letrozole/>, <https://onco.cc/drugs/fulvestrant/>, <https://onco.cc/drugs/enzalutamide/> ;
  onco:companies <https://onco.cc/companies/pfizer/> .